Needham Keeps Buy Rating for CorMedix, PT Drops to $14

Friday, Mar 6, 2026 6:02 am ET1min read
CRMD--

Needham Keeps Buy Rating for CorMedix, PT Drops to $14

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet